Regular‐dose postoperative 5‐Fluorouracil showed no clear difference in complications ‐ wound leak ‐ primary trabeculectomy compared with control (low certainty).
Regular‐dose postoperative 5‐Fluorouracil showed no clear difference in complications ‐ shallow anterior chamber ‐ primary trabeculectomy compared with control (low certainty).
Regular‐dose postoperative 5‐Fluorouracil may leads to higher complications ‐ epithelial toxicity ‐ primary trabeculectomy compared with control (low certainty).
It is very uncertain whether low‐dose postoperative 5‐Fluorouracil changes failure at 12 months compared with control (very low certainty).
It is very uncertain whether low‐dose postoperative 5‐Fluorouracil changes complications ‐ wound leak compared with control (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Regular‐dose postoperative 5‐Fluorouracil showed no clear difference in complications ‐ wound leak compared with control (low certainty).
The review found no eligible studies for this question.
Intraoperative 5‐Fluorouracil showed no clear difference in complications ‐ wound leak compared with placebo or control (high certainty).
Intraoperative 5‐Fluorouracil showed no clear difference in complications ‐ hypotonous maculopathy compared with placebo or control (moderate certainty).
Intraoperative 5‐Fluorouracil leads to higher complications ‐ shallow anterior chamber compared with placebo or control (high certainty).
Intraoperative 5‐Fluorouracil showed no clear difference in complications ‐ epithelial toxicity compared with placebo or control (moderate certainty).
The review found no eligible studies for this question.
Regular‐dose postoperative 5‐Fluorouracil showed no clear difference in complications ‐ shallow anterior chamber compared with control (low certainty).
Regular‐dose postoperative 5‐Fluorouracil may leads to higher complications ‐ epithelial toxicity compared with control (low certainty).
Regular‐dose postoperative 5‐Fluorouracil probably leads to lower failure at 12 months ‐ high risk of failure compared with control (moderate certainty).